Male Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH)

被引:175
作者
Roehrborn, Claus G. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
关键词
Lower urinary tract symptoms (LUTS); Benign prostatic hyperplasia (BPH); Medical therapy; alpha blocker; 5-alpha-Reductase inhibitors; Antimuscarinics; TOLTERODINE EXTENDED-RELEASE; QUALITY-OF-LIFE; OVERACTIVE BLADDER; COMBINATION THERAPY; OUTLET OBSTRUCTION; NATURAL-HISTORY; CLINICAL PROGRESSION; MEN; VOLUME; TAMSULOSIN;
D O I
10.1016/j.mcna.2010.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Male lower urinary tract symptoms, benign prostatic hyperplasia, enlargement of the prostate, and bladder outlet obstruction are common among aging men and will increase in socioeconomic and medical importance at a time of increased life expectancy and aging of the baby boomer generation. This article reviews the epidemiology, management, and therapeutic options for these conditions. In patients bothered by moderate to severe symptoms, providers can make educated and differential choices between several classes of drugs, alone or in combination, to treat effectively and improve the symptoms in most men. Despite the efficacy of medical therapy, there will be patients who require referral to a urologist either early, to rule out prostate cancer and other conditions, or later, after initial medical therapy and lifestyle management has failed. Perhaps as many as 30% of patients fail to achieve sufficient symptom improvement with medication, lifestyle adjustment, and fluid management, and may require more invasive or surgical treatment options.
引用
收藏
页码:87 / +
页数:15
相关论文
共 51 条
[1]   Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction [J].
Abrams, P ;
Kaplan, S ;
Gans, HJD ;
Millard, R .
JOURNAL OF UROLOGY, 2006, 175 (03) :999-1004
[2]   Evaluation and Treatment of Lower Urinary Tract Symptoms in Older Men [J].
Abrams, P. ;
Chapple, C. ;
Khoury, S. ;
Roehrborn, C. ;
de la Rosette, J. .
JOURNAL OF UROLOGY, 2009, 181 (04) :1779-1787
[3]   The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society (Reprinted from Neurourology and Urodynamics, vol 21, pg 167-178, 2002) [J].
Abrams, P ;
Cardozo, L ;
Fall, M ;
Griffiths, D ;
Rosier, P ;
Ulmsten, U ;
Van Kerrebroeck, P ;
Victor, A ;
Wein, A .
UROLOGY, 2003, 61 (01) :37-49
[4]  
Abrams P, 2006, J UROLOGY, V175
[5]   Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder [J].
Athanasopoulos, AA ;
Perimenis, PS .
BJU INTERNATIONAL, 2005, 95 (07) :1117-1118
[7]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[8]  
Barry MJ, 1992, J UROLOGY, V148, P1564
[9]   Saw palmetto for benign prostatic hyperplasia [J].
Bent, S ;
Kane, C ;
Shinohara, K ;
Neuhaus, J ;
Hudes, ES ;
Goldberg, H ;
Avins, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :557-566
[10]   Serum prostate-specific antigen as a predictor of prostate volume in the community: The krimpen study [J].
Bohnen, Arthur M. ;
Groeneveld, Frans P. ;
Bosch, J. L. H. Ruud .
EUROPEAN UROLOGY, 2007, 51 (06) :1645-1653